Dogwood Therapeutics
(NASDAQ) DWTX
Dogwood Therapeutics Financials at a Glance
Market Cap
$70.48M
Revenue (TTM)
$0.00
Net Income (TTM)
$34.26M
EPS (TTM)
$-18.91
P/E Ratio
-0.11
Dividend
$0.00
Beta (Volatility)
0.75 (Low)
Dividend
$0.00
Beta (Volatility)
0.75 (Low)
Price
$2.13
Volume
65,983
Open
$2.02
Price
$2.13
Volume
65,983
Open
$2.02
Previous Close
$2.13
Daily Range
$2.02 - $2.35
52-Week Range
$1.77 - $9.50
Dividend
$0.00
Beta (Volatility)
0.75 (Low)
Price
$2.13
Volume
65,983
Open
$2.02
Previous Close
$2.13
Daily Range
$2.02 - $2.35
52-Week Range
$1.77 - $9.50
DWTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Dogwood Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Gregory Duncan, MBA
Website
www.dwtx.comHeadquarters
Alpharetta, GA 30009, US
DWTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-106%
Return on Capital
-32%
Return on Assets
-38%
Earnings Yield
-9.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$70.48M
Shares Outstanding
33.40M
Volume
65.98K
Short Interest
0.00%
Avg. Volume
57.27K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$27.97M
EBITDA
$27.97M
Operating Cash Flow
$15.62M
Capital Expenditure
$0.00
Free Cash Flow
$15.62M
Cash & ST Invst.
$6.52M
Total Debt
$162.60K
Dogwood Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$70.48M
N/A
Market Cap/Employee
$5.87M
N/A
Employees
12
N/A
Net Income
$3.78M
+51.1%
EBITDA
$3.81M
+49.7%
Quarterly Fundamentals
Net Cash
$6.36M
+962.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$105.76K
-99.3%
Short Term Debt
$56.84K
-42.8%
Return on Assets
-37.99%
N/A
Return on Invested Capital
-32.11%
N/A
Free Cash Flow
$3.64M
+40.7%
Operating Cash Flow
$3.64M
+40.7%